The Ministry Of Health, By Force Of Court Order, Summons Companies Interested In Supplying, Via Direct Contracting, The Following Strategic Health Input: Selumetinib Concentration: 10 Mg; Regorafenib Concentration: 40 Mg; Bendamustine Concentration: 100 Mg Pharmaceutical Form: Lyophilized Powder For Injection; Teriparatide Concentration: 250 Mcg/Ml Pharmaceutical Form: Injectable Solution Additional Characteristics: With Delivery System; Ribociclib Composition: Succinate Concentration: 200 Mg; Dupilumab Concentration: 175 Mg/Ml Pharmaceutical Form: Injectable Solution Additional: Prefilled Syringe; Dupilumab Concentration: 150 Mg/Ml Pharmaceutical Form: Injectable Solution Additional: Prefilled Syringe; Canakinumab Concentration: 150 Mg Pharmaceutical Form: Lyophilized Powder For Injection; Nintedanib Composition: Esylate Salt Concentration: 150 Mg And Medicinal Extract Active Ingredient: Cannabidiol Oil Concentration: 60 Mg/Ml Pharmaceutical Form: Oral Solution - Drops Ecs Care 6000Mg - Central Pharma Care.
Invitation for Bids
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any updates, corrections, or complaints related to this notice, please contact the responsible purchaser directly.
